GATA3 and Parkinson disease: Taking into account some of the qualities of an ideal biomarker—to be safe, minimally invasive, inexpensive and rapid but accurately measurable—we sought to measure the expression of GATA3 in the blood of idiopathic PD (iPD) patients and controls without PD (non-PD) using quantitative reverse transcription PCR (RT-qPCR).